Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
177.00    3.35 (1.93%)
Bid:
176.80
Ask:
176.90
Spread: 0.10 (0.057%)
Market Cap: £8.02b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Transaction in Own Shares

16 May 2025 07:00

RNS Number : 9130I
Centrica PLC
16 May 2025
 

Transactions in own shares

 

Centrica plc

16 May 2025

 

Centrica plc announces that it purchased on 15 May 2025 (through Merrill Lynch International) 4,796,475 Centrica plc ordinary shares of 6 14/81 pence each at a price of 148.46 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the extension of the Company's 2024-25 buyback programme announced on 27 December 2024 and in accordance with the non-discretionary share repurchase agreement entered into with Merrill Lynch International as also announced on 27 December 2024, which agreement was subsequently amended as announced on 3 March 2025.

 

Since 3 March 2025, Centrica has purchased 95,758,941 ordinary shares at a cost (excluding dealing and associated costs) of £143,327,715.11.

 

Following the above purchase, Centrica plc holds 518,485,961 ordinary shares in treasury, and has 4,974,621,253 ordinary shares in issue (excluding treasury shares).

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Merrill Lynch International is set out below.

 

Transaction details: Centrica plc ordinary shares of 6 14/81 pence each

 

Issuer name:

Centrica plc

ISIN:

GB00B033F229

Intermediary name:

Merrill Lynch International

Intermediary Code:

MLILGB3LESF

Currency:

GBP

 

Aggregated information

Date of purchase:

15 May 2025

Number of ordinary shares purchased:

4,796,475

Highest price paid:

149.20p

Lowest price paid:

146.05p

Volume weighted average price paid per share:

148.46p

 

Disaggregated information

 

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/9130I_1-2025-5-15.pdf

 

END

 

Enquiries:

Investors and Analysts

E: ir@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZGMKVKKGKZM
Date   Source Headline
15th May 20246:00 pmRNSTransaction in Own Shares
15th May 20244:18 pmRNSDirector Declaration
15th May 20249:04 amRNSStabilisation Notice
14th May 20246:10 pmRNSTransaction in Own Shares
14th May 202412:16 pmRNSStabilisation Notice
14th May 20248:59 amRNSStabilisation Notice
13th May 20246:15 pmRNSDirector/PDMR Shareholding
13th May 20246:15 pmRNSTransaction in Own Shares
10th May 20246:00 pmRNSTransaction in Own Shares
10th May 20249:07 amRNSCentrica announces new issue and tender offer
9th May 20246:00 pmRNSTransaction in Own Shares
8th May 20246:00 pmRNSTransaction in Own Shares
7th May 20246:00 pmRNSTransaction in Own Shares
3rd May 20246:00 pmRNSTransaction in Own Shares
2nd May 20246:00 pmRNSTransaction in Own Shares
1st May 20246:00 pmRNSTransaction in Own Shares
1st May 20245:00 pmRNSBlock listing Interim Review
1st May 20244:30 pmRNSTotal Voting Rights
30th Apr 20246:00 pmRNSTransaction in Own Shares
29th Apr 20246:00 pmRNSTransaction in Own Shares
26th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20245:30 pmRNSDirector/PDMR Shareholding
25th Apr 20242:00 pmRNSNotice of AGM
24th Apr 20246:00 pmRNSTransaction in Own Shares
23rd Apr 20246:00 pmRNSTransaction in Own Shares
22nd Apr 20246:00 pmRNSTransaction in Own Shares
19th Apr 20246:00 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSTransaction in Own Shares
17th Apr 20246:00 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:25 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20241:30 pmRNSDirector/PDMR Shareholding
10th Apr 20246:00 pmRNSTransaction in Own Shares
9th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20245:30 pmRNSDirector Declaration
4th Apr 20246:00 pmRNSTransaction in Own Shares
3rd Apr 20246:00 pmRNSTotal Voting Rights - Replacement
3rd Apr 20246:00 pmRNSTransaction in Own Shares
2nd Apr 20246:25 pmRNSTransaction in Own Shares
2nd Apr 20241:00 pmRNSTotal Voting Rights
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:25 pmRNSTransaction in Own Shares
26th Mar 20246:30 pmRNSTransfer of Treasury Shares
26th Mar 20246:00 pmRNSTransaction in Own Shares
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.